ANIK

Anika Therapeutics Inc
Data: 2026-01-30
$9.23
Price
1.09%
Change
$18.37
52W High
$7.8701
52W Low

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

Quick Stats
Jan 30, 2026

54.0

AI Score

HOLD

1.21

Volume Ratio

Mar 11, 2026

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

ANIK Stock Summary

Last updated Jan 30, 2026

ANIK is currently trading at $9.23, positioned below its 200-day moving average of $10.27, suggesting bearish momentum. The stock has a 52-week range of $7.8701 to $18.37.

Technical Analysis: The 50-day moving average stands at $9.52, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 42.917, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.002, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ANIK at 54.0/100 with a HOLD recommendation.

ANIK (Anika Therapeutics Inc) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 42.917
CMF (20) 0.002
ROC (10) -3.148
ADX (14) 22.181
Indicator Value
MACD (12,26,9) -0.103
AROONOSC (14) -85.714
WILLAMS %R (14) -63.945
MFI (14) 22.234
ANIK Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ANIK Price vs Max Options Open Interest
ANIK Max Change In Options Open Interest

ANIK Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ANIK Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ANIK Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ANIK Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Anika Therapeutics Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

ANIK Moving Averages Analysis

ANIK (Anika Therapeutics Inc) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 9.29
20 9.42
30 9.45
50 9.52
100 9.44
200 10.27

ANIK Fundamental Analysis

P/E (Forward) 35.2113
P/E (Trailing) --
Market Cap ($) 131.7 million
Earnings/Share ($) -0.99
Net Proft Margin (%) -0.2929
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.13
EPS Estimate Next Year ($) 0.26
WallStreet Target Price ($) 16
Most Recent Quarter